comparemela.com
Home
Live Updates
Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) : comparemela.com
Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
Related Keywords
Sylvia Wheeler ,
Sarah Mathieson ,
Prnewswire Eiger Biopharmaceuticals Inc ,
Eiger Biopharmaceuticals Inc ,
Compensation Committee Of Eiger Board Directors ,
Corporate Affairs ,
Nasdaq ,
Compensation Committee ,
Eiger Biopharmaceuticals ,
Nasdaq Listing Rule ,
Life Science Advisors ,
comparemela.com © 2020. All Rights Reserved.